Helmholtz Gemeinschaft


Cardiovascular magnetic resonance for patients with COVID-19

Item Type:Review
Title:Cardiovascular magnetic resonance for patients with COVID-19
Creators Name:Petersen, S.E. and Friedrich, M.G. and Leiner, T. and Elias, M.D. and Ferreira, V.M. and Fenski, M. and Flamm, S.D. and Fogel, M. and Garg, R. and Halushka, M.K. and Hays, A.G. and Kawel-Boehm, N. and Kramer, C.M. and Nagel, E. and Ntusi, N.A.B. and Ostenfeld, E. and Pennell, D.J. and Raisi-Estabragh, Z. and Reeder, S.B. and Rochitte, C.E. and Starekova, J. and Suchá, D. and Tao, Q. and Schulz-Menger, J. and Bluemke, D.A.
Abstract:COVID-19 is associated with myocardial injury caused by ischemia, inflammation, or myocarditis. Cardiovascular magnetic resonance (CMR) is the noninvasive reference standard for cardiac function, structure, and tissue composition. CMR is a potentially valuable diagnostic tool in patients with COVID-19 presenting with myocardial injury and evidence of cardiac dysfunction. Although COVID-19-related myocarditis is likely infrequent, COVID-19-related cardiovascular histopathology findings have been reported in up to 48% of patients, raising the concern for long-term myocardial injury. Studies to date report CMR abnormalities in 26% to 60% of hospitalized patients who have recovered from COVID-19, including functional impairment, myocardial tissue abnormalities, late gadolinium enhancement, or pericardial abnormalities. In athletes post-COVID-19, CMR has detected myocarditis-like abnormalities. In children, multisystem inflammatory syndrome may occur 2 to 6 weeks after infection; associated myocarditis and coronary artery aneurysms are evaluable by CMR. At this time, our understanding of COVID-19-related cardiovascular involvement is incomplete, and multiple studies are planned to evaluate patients with COVID-19 using CMR. In this review, we summarize existing studies of CMR for patients with COVID-19 and present ongoing research. We also provide recommendations for clinical use of CMR for patients with acute symptoms or who are recovering from COVID-19.
Keywords:Cardiovascular Magnetic Resonance, COVID-19, Ischemia, Multisystem Inflammatory Syndrome, Myocardial Injury, Myocarditis, SARS-CoV-2
Source:JACC: Cardiovascular Imaging
Page Range:685-699
Date:April 2021
Official Publication:https://doi.org/10.1016/j.jcmg.2021.08.021
PubMed:View item in PubMed

Repository Staff Only: item control page

Open Access
MDC Library